Discover

KRRO
Korro Bio, Inc.
11.82
1 x 11.77
1 x 11.83
bid
ask
-
0.14
1.17%
12:02 PM
timesize
Ytd47.57%
1y-16.70%
11.56
day range
12.07
5.20
52 week range
55.89
Open11.89Prev Close11.96Low11.56High12.07Mkt Cap119.04M
Vol37.80KAvg Vol187.84KEPS-11.67P/E-1.02Forward P/E-4.29
Beta3.00Short Ratio2.64Inst. Own91.36%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg12.20200-d Avg15.411yr Est137.76
Income Statement
Operating Expenses20.44M
Research and Development Expense12.95M
Selling, General and Administrative Expense7.49M
Operating Income-20.44M
Income Tax Expense95.00K
Net Income-19.62M
Net Income Common Stock-19.62M
Net Income Common Stock (USD)-19.62M
Consolidated Income-19.62M
Earnings per Basic Share-1.69
Earnings per Basic Share (USD)-1.69
Earnings per Diluted Share-1.69
Earning Before Interest & Taxes (EBIT)-19.53M
Earning Before Interest & Taxes (USD)-19.53M
Weighted Average Shares11.60M
Weighted Average Shares Diluted11.60M
Balance Sheet
Cash and Equivalents61.70M
Cash and Equivalents (USD)61.70M
Investments97.77M
Investments Current52.27M
Investments Non-Current45.49M
Current Assets120.16M
Property, Plant & Equipment Net15.62M
Total Assets183.62M
Debt Current2.80M
Total Debt42.89M
Current Liabilities14.79M
Debt Non-Current40.08M
Total Liabilities63.99M
Accumulated Retained Earnings (Deficit)-403.47M
Accumulated Other Comprehensive Income5.00K
Shareholders Equity119.63M
Shareholders Equity (USD)119.63M
Assets Non-Current63.46M
Total Debt (USD)42.89M
Deferred Revenue7.84M
Liabilities Non-Current49.20M
Trade and Non-Trade Payables1.96M
Cash Flow
Depreciation, Amortization & Accretion622.00K
Net Cash Flow from Financing88.21M
Net Cash Flow / Change in Cash & Cash Equivalents39.87M
Capital Expenditure-21.00K
Issuance (Purchase) of Equity Shares88.21M
Net Cash Flow from Investing-32.24M
Net Cash Flow - Investment Acquisitions and Disposals-32.22M
Net Cash Flow from Operations-16.07M
Effect of Exchange Rate Changes on Cash -25.00K
Share Based Compensation2.73M